Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Brain Neoplasms

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Brain Neoplasms in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saitoh, K1
Mikuni, M1
Ikeda, M1
Yamazaki, C1
Tomita, U1
Takahashi, K1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Brain Neoplasms

ArticleYear
Serotonin-induced 5-HT1A receptor desensitization in C6BU-1 glioma cells transfected with 5-HT1A receptor gene.
    Neuroscience letters, 1995, Oct-27, Volume: 199, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain Neoplasms; Colforsin; Cyclic AMP; Dose-Respon

1995